17 Nov 08 Enrollment In EMERALD 1 Complete, 3rd Of 4 Phase 3 Clinical Trials Of Hematide™ To Treat Anemia In Chronic Renal Failure Patients
Affymax, Inc. (Nasdaq:AFFY) today announced that enrollment has been completed in EMERALD 1, one of its Phase 3 clinical trials of its lead investigational therapy, Hematide™, which is being evaluated for the treatment of anemia in chronic renal failure patients. EMERALD 1 includes over 800 dialysis patients from over 90 sites in the United States.
(more…)
Tags: Affy, Anemia, Chronic Renal Failure, Clinical Trials, Dialysis Patients, Emerald, Failure Patients, Hematide, Lead, Nasdaq, Phase 3, Treatment Failure, Treatment Of Anemia, United States
14 Nov 08 Molecule That Stops SARS Invented By Purdue Researcher
A Purdue University researcher has created a compound that prevents replication of the virus that causes SARS and could lead to a treatment for the disease. “The outbreak of SARS in 2003 led to hundreds of deaths and thousands of illnesses, and there is currently no treatment,” said Arun Ghosh, the Purdue professor that led the molecular design team. “Although it is not currently a threat, there is the concern that SARS could return or be used as a biological weapon.
(more…)
Tags: Biological Weapon, Deaths, Illnesses, Lead, Led, Molecule, Outbreak, Purdue Professor, Purdue Researcher, Purdue University Researcher, Replication, Sars, Virus
12 Nov 08 Soft Contact Lenses Do Not Lead To "Myopic Creep" In Children, Study Shows
Soft contact lens wear does not result in clinically significant acceleration in the development of nearsightedness in children and does not cause relevant increases in axial length or corneal curvature, a new study shows. Findings from the three-year study, the largest randomized trial of its kind, appear in the November issue of Investigative Ophthalmology & Visual Science, the official journal of The Association for Research in Vision and Ophthalmology.
(more…)
Tags: Acceleration, Amp, Axial Length, Contact Lens, Corneal Curvature, Investigative Ophthalmology, Lead, Nearsightedness, Randomized Trial, Soft Contact Lenses, Soft Lens, Visual Science
12 Nov 08 Molecule That Stops SARS Invented By Purdue Researcher
A Purdue University researcher has created a compound that prevents replication of the virus that causes SARS and could lead to a treatment for the disease. “The outbreak of SARS in 2003 led to hundreds of deaths and thousands of illnesses, and there is currently no treatment,” said Arun Ghosh, the Purdue professor that led the molecular design team. “Although it is not currently a threat, there is the concern that SARS could return or be used as a biological weapon.
(more…)
Tags: Biological Weapon, Deaths, Illnesses, Lead, Led, Molecule, Outbreak, Purdue Professor, Purdue Researcher, Purdue University Researcher, Replication, Sars, Virus
09 Nov 08 Gene Expression In The Brain Can Be Altered By Social Interactions, And Vice Versa
Our DNA determines a lot about who we are and how we play with others, but recent studies of social animals (birds and bees, among others) show that the interaction between genes and behavior is more of a two-way street than most of us realize. This is not a new idea to neuroscience, but one that is gaining strength, said University of Illinois entomology and neuroscience professor Gene Robinson, lead author of a review on the subject this week in the journal Science.
(more…)
Tags: Animals Birds, Birds And Bees, Brain, Dna, Entomology, Gene Expression, Genes And Behavior, Interaction, Journal Science, Lead, Neuroscience, Social Animals, Social Interactions, University Of Illinois, Vice Versa
08 Nov 08 Repairing DNA Damage: Researchers Discover Critical Process In Cancer Treatment
From the sun’s UVA rays to tobacco smoke, our environment is chock-full of DNA-damaging agents that can lead to cancer. Thanks to our body’s DNA repair mechanisms, however, the effects of many carcinogens can be reversed thereby preventing the formation of tumours.
(more…)
Tags: Cancer Treatment, Carcinogens, Discover, Dna Damage, Dna Repair Mechanisms, Lead, Sun, Tobacco Smoke, Tumours, Uva Rays
08 Nov 08 The Search For Sensitive Sensors Boosted By Winning University Of Melbourne Ph.D. Research
Research that could lead to brighter LCD screens, more efficient solar panels, improved biomedical imaging and high-tech security sensors has won the University of Melbourne’s Chancellor’s Prize for Excellence in PhD. Dr Daniel Gomez, who completed his thesis in the School of Chemistry, has shed new light on the properties of semiconductor nano-crystals, particles only a billionth of a metre long.
(more…)
Tags: Billionth, Biomedical Imaging, Chancellor, Chemistry, Daniel Gomez, Dr Daniel, Lcd Screens, Lead, Particles, Phd, Security Sensors, Semiconductor Crystals, Sensitive Sensors, Shed, Solar Panels, Thesis, University Melbourne, University Of Melbourne
07 Nov 08 Scientists coax brain cells in mice to regenerate
CHICAGO (Reuters) - Scientists have found a way to get damaged nerve cells in the brains of mice to repair themselves, a finding that may lead to new treatments for spinal cord and brain injuries.
Tags: Brain Cells, Brain Injuries, Brains, Lead, Mice, Nerve Cells, Reuters, Scientists, Spinal Cord, Spinal Injuries
07 Nov 08 Alcohol Abuse Can Damage Bones (HealthDay)
HealthDay - THURSDAY, Nov. 6 (HealthDay News) — Alcohol disrupts genes
needed to maintain healthy bones, which can lead to a decrease in bone
mass and bone strength, a new study says.
(more…)
Tags: Alcohol Abuse, Bone Mass, Bone Strength, Genes, Healthday, Healthy Bones, Lead
06 Nov 08 Alcohol Abuse Can Damage Bones (HealthDay)
HealthDay - THURSDAY, Nov. 6 (HealthDay News) — Alcohol disrupts genes
needed to maintain healthy bones, which can lead to a decrease in bone
mass and bone strength, a new study says.
(more…)
Tags: Alcohol Abuse, Bone Mass, Bone Strength, Genes, Healthday, Healthy Bones, Lead
06 Nov 08 Mirrors Made With Highly Reflective Liquids May Lead To Better Eye Exams, Improved Telescopes
Scientists in Canada are reporting progress toward a new type of “liquid mirror” - mirrors made with highly reflective liquids - whose shape can be changed to provide superior optical properties over conventional solid mirrors. The advance could lead to improved instruments for diagnosing eye disease, more powerful telescopes, and other applications, the researchers say. Their research will be described in the November 25 issue of ACS’ Chemistry of Materials, a bi-weekly journal.
(more…)
Tags: Acs, Acs Chemistry, Applications, Canada, Chemistry Of Materials, Eye Disease, Eye Exams, Lead, Liquid Mirror, Liquids, Mirrors, Optical Properties, Scientists, Shape, Telescopes
05 Nov 08 Study: Women lead men in bacteria, hands down
WASHINGTON (AP) — Wash your hands, folks, especially you ladies. A new study found that women have a greater variety of bacteria on their hands than men do. And everybody has more types of bacteria than the researchers expected to find….
(more…)
Tags: Lead, Study Women, Types Of Bacteria, Variety, Wash Your Hands
05 Nov 08 Study: Women lead men in bacteria, hands down (AP)
AP - Wash your hands, folks, especially you ladies. A new study found that women have a greater variety of bacteria on their hands than men do. And everybody has more types of bacteria than the researchers expected to find.
(more…)
Tags: Lead, Study Women, Types Of Bacteria, Variety, Wash Your Hands
05 Nov 08 Safety a problem for new generation drugs, too (AP)
AP - Nearly a fourth of widely used new-generation biological drugs for several common diseases produce serious side effects that lead to safety warnings soon after they go on the market, the first major study of its kind found.
(more…)
Tags: Common Diseases, Lead, New Drugs, New Generation, Safety Warnings
05 Nov 08 Warm hands lead to warm hearts, sneaky study shows (AP)
AP - Time to update that old saying “cold hands, warm heart.” New research shows touching something warm can make you feel and act more warmly toward others.
(more…)
Tags: Cold Hands, Heart Research, Lead, Warm Hands, Warm Heart, Warm Hearts
05 Nov 08 Safety a problem for new generation drugs, too (AP)
AP - Nearly a fourth of widely used new-generation biological drugs for several common diseases produce serious side effects that lead to safety warnings soon after they go on the market, the first major study of its kind found.
(more…)
Tags: Common Diseases, Lead, New Drugs, New Generation, Safety Warnings
05 Nov 08 Shedding Light On Genetic Differences That Cause A Childhood Eye Disease
Medical researchers at the University of Alberta have unlocked part of the mystery underlying a childhood eye disease. New research shows how children with some types of glaucoma end up with missing or extra pieces of DNA. The missing or extra bits of DNA are called copy number variations (CNVs). The U of A research team had previously shown how they play a major role in causing some types of pediatric glaucoma - a disease that can lead to blindness.
(more…)
Tags: Blindness, Childhood Disease, Dna, Eye Disease, Genetic Differences, Glaucoma, Lead, Medical Researchers, Mystery, Pediatric Glaucoma, Types Of Glaucoma, University Of Alberta, Variations
05 Nov 08 Elaine Hill Appointed As The New Specialist Advisor For Autism, Dept Of Health, UK
Elaine Hill has been appointed as the new Specialist Advisor for Autism at the Department of Health. Working four days a week, Elaine’s responsibilities in her new role will be to lead the development of an adult autism strategy. She will advise on the needs of people with autistic spectrum conditions (ASC) in policy work on projects for social care and health services.
(more…)
Tags: Adult, Autism Uk, Autistic Spectrum, Department Of Health, Dept Of Health, Elaine Hill, Health Services, Health Uk, Lead, People, Social Health, Social Services
05 Nov 08 FDA Accepts Arana’s Anti-inflammatory IND
Biotechnology company Arana Therapeutics Limited (ASX: AAH) announced that lead anti-inflammatory compound, ART621 has successfully passed review of its rheumatoid arthritis Investigational New Drug (IND) application by the US Food and Drug Administration (FDA). IND status indicates regulatory approval to conduct clinical trials in humans in the United States and represents the first review of ART621 data by a major Regulatory Authority.
(more…)
Tags: Anti Inflammatory, Arana, Arthritis, Asx, Biotechnology Company, Clinical Trials, Fda, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Lead, Limited, Regulatory Approval, Regulatory Authority, Rheumatoid Arthritis, United States, Us Food And Drug Administration
05 Nov 08 Affymax Completes Enrollment In PEARL 2, 2nd Of 4 Phase 3 Clinical Trials Of Hematide To Treat Anemia In Chronic Renal Failure Patients
Affymax, Inc. (Nasdaq:AFFY) today announced that enrollment has been completed in the second of four Phase 3 clinical trials of its lead investigational therapy, Hematide™, which is being evaluated for the treatment of anemia in chronic renal failure patients. PEARL 2 (Phase 3 Evaluation of Hematide for Anemia Correction in Chronic Renal Failure) is fully enrolled with over 490 non-dialysis patients from over 60 sites in the United States and Europe.
(more…)
Tags: Affy, Anemia, Chronic Renal Failure, Clinical Trials, Dialysis Patients, Europe, Failure Patients, Hematide, Lead, Nasdaq, Phase 3, Treatment Failure, Treatment Of Anemia, United States
